INO 8-K: SEC filing
Inovio Pharmaceuticals
Filed with the SEC on · accession 0001193125-26-449853
INO filed a 8-K (current report) with the SEC on Nov 5, 2026. Inovio Pharmaceuticals disclosed preliminary unaudited estimates that its cash, cash equivalents, and short-term investments were approximately $48.4 million as of September 30, 2026. The stock moved -10.5% by the first close after the filing.
Summary of the filing
Inovio Pharmaceuticals disclosed preliminary unaudited estimates that its cash, cash equivalents, and short-term investments were approximately $48.4 million as of September 30, 2026. The company also referenced a prospectus supplement filed the same day, suggesting a concurrent securities offering.
Key details
How INO stock reacted
Close before
$1.62
Nov 4, 2026
First close after
-10.49%
$1.45
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for INO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for INO?
Click hereFrequently asked questions
What did INO file with the SEC on Nov 5, 2026?
INO filed a 8-K (SEC filing). Inovio Pharmaceuticals disclosed preliminary unaudited estimates that its cash, cash equivalents, and short-term investments were approximately $48.4 million as of September 30, 2026. The company also referenced a prospectus supplement filed the same day, suggesting a concurrent securities offering.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did INO stock react to this filing?
INO closed at $1.62 before the filing and $1.45 on Nov 5, 2026 (-10.49%).
Other INO SEC filings
- 8-K · Fda approvalNov 2, 2026
- 8-K · SEC filingOct 6, 2026
- 10-Q · SEC filingAug 12, 2026
- 8-K · SEC filingAug 12, 2026
- 8-K · Secondary offeringJul 31, 2026
- 424B5 · Secondary offeringJul 30, 2026
- 424B5 · Secondary offeringJul 29, 2026
- 8-K · SEC filingJul 29, 2026
- EFFECT · SEC filingJul 10, 2026
- S-3 · Shelf registrationJul 2, 2026
Get alerts when INO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days